scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10072-017-2912-Y |
P698 | PubMed publication ID | 28367610 |
P2093 | author name string | Ying Tang | |
Dongfeng Li | |||
Jiliang Wang | |||
Yurong Tang | |||
Qingbo Ren | |||
Shunfeng Zhao | |||
P2860 | cites work | Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 |
The 2007 WHO classification of tumours of the central nervous system | Q24685772 | ||
MicroRNA signatures in human cancers | Q27860962 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R. | Q34442762 | ||
Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia | Q35857675 | ||
Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma | Q36560956 | ||
MiR-122 targets VEGFC in bladder cancer to inhibit tumor growth and angiogenesis | Q37144069 | ||
Genetics of adult glioma | Q38067239 | ||
MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner | Q38738609 | ||
Decreased expression of microRNA-148a predicts poor prognosis in ovarian cancer and associates with tumor growth and metastasis | Q38738742 | ||
WNT1 Gene from WNT Signaling Pathway Is a Direct Target of miR-122 in Hepatocellular Carcinoma | Q38743109 | ||
The expression of miRNA-221 and miRNA-222 in gliomas patients and their prognosis | Q38746253 | ||
Reduced expression of microRNA-497 is associated with greater angiogenesis and poor prognosis in human gliomas | Q38749535 | ||
MiR-122/Wnt/β-catenin regulatory circuitry sustains glioma progression | Q38991254 | ||
Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study. | Q39217323 | ||
Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer | Q39598466 | ||
Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma | Q39754560 | ||
Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer | Q40579865 | ||
Evaluation of miR-122 level in the plasma of chronically HCV infected patients | Q40653866 | ||
Upregulation of miR-183 expression and its clinical significance in human brain glioma | Q40740363 | ||
Identification and Evaluation of Serum MicroRNA-29 Family for Glioma Screening | Q48466686 | ||
Plasma miR-454-3p as a potential prognostic indicator in human glioma | Q48563610 | ||
Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma. | Q53624071 | ||
Overexpression of microRNA-155 predicts poor prognosis in glioma patients. | Q55461092 | ||
Downregulation of microRNA-139 is associated with hepatocellular carcinoma risk and short-term survival | Q87319232 | ||
P433 | issue | 6 | |
P304 | page(s) | 1087-1092 | |
P577 | publication date | 2017-04-03 | |
P1433 | published in | Neurological Sciences | Q15763262 |
P1476 | title | Plasma miR-122 as a potential diagnostic and prognostic indicator in human glioma | |
P478 | volume | 38 |
Q47226900 | Biomarkers in Spinal Cord Injury: from Prognosis to Treatment |
Q64240657 | Clinical value of miRNA-122 in the diagnosis and prognosis of various types of cancer |
Q104690914 | Comprehensive Characterization of Nanosized Extracellular Vesicles from Central and Peripheral Organs : Implications for Preclinical and Clinical Applications |
Q60301685 | Liquid biopsy for pediatric central nervous system tumors |
Q64899756 | MicroRNA based theranostics for brain cancer: basic principles. |
Q50073558 | News on the journal Neurological Sciences in 2017. |
Q92669998 | Serum exosomal miR-122 as a potential diagnostic and prognostic biomarker of colorectal cancer with liver metastasis |
Q55456731 | microRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis. |
Search more.